Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Matei, Daniela
Professor
Bio
In the laboratory, specific interests have been investigating tumor-stroma interactions which regulate ovarian cancer metastasis, characterizing and targeting ovarian cancer stem cells, studying growt... [more]
Meeks, Joshua
Associate Professor
Bio
My research laboratory is focused on the molecular pathways involved in the progression of urothelial carcinoma (bladder cancer). My research has two themes: 1) to investigate the ... [more]
Melo-Cardenas, Johanna
Assistant Professor
Bio
My research aims to understand the molecular mechanisms of immune cell mediated inflammation and the cellular relationships between the bone marrow microenvironment and malignant clones in myeloid blo... [more]
Mirkin, Chad
Professor
Bio
Prof. Mirkin has pioneered the use of nanoparticle-biomolecule conjugates as synthons in materials science and the development of many nanoparticle-based extra- and intracellular biodiagnostic and the... [more]
Miska, Jason
Assistant Professor
Bio
The goal of Dr. Miska's research is to determine how the metabolism of immune cells within glioblastoma contributes to immune suppression and tumor recurrence. Furthermore, the long-term goal of ... [more]
Mohindra, Nisha
Associate Professor
Bio
Her research interests focus on the clinical investigation of novel agents or combination therapies for non-small cell and small cell lung cancer. She is also interested in developing quality of life ... [more]
Mulcahy, Mary F.
Professor
Bio
Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer
Opal, Puneet
Professor
Bio
As a physician-scientist, I specialize in movement disorders. I established and currently direct Northwestern's Denning Ataxia Clinic, where my interactions with patients fuel my laboratory'... [more]
Patel, Jyoti D.
Professor
Bio
I am a medical oncologist with expertise in clinical and translational research in thoracic cancers and clinical drug development. I have led multiple clinical trials with novel drugs at all levels, f... [more]
Peter, Marcus
Professor
Bio
Dr. Peter has been working in the apoptosis and death receptor field for 19 years. His initial work in 1995 described the first multiprotein complex in apoptosis, the CD95 death-inducing signaling com... [more]